Immunomodulatory bioactivity of soy and milk ferments on monocyte and macrophage models

Food Research International

Volumn 44, Issue 8, 2011, Pages 2475-2481

  Masotti, A I ^a   Buckley, N ^b   Champagne, C P ^c   Green Johnson, J ^a  

^a UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

^b CANADIAN SPACE AGENCY   (Canada)

^c FOOD RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Bifidobacterium longum; Bioactivity; Immune; Lactobacillus helveticus; Milk; Probiotic; Soymilk; U937

Indexed keywords

BIFIDOBACTERIUM LONGUM; IMMUNE; LACTOBACILLUS HELVETICUS; MILK; PROBIOTICS; SOY MILK; U937;

BODY FLUIDS; CELL MEMBRANES; DAIRIES; FERMENTED MILK; MACROPHAGES;

ENZYMES;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM LONGUM; GLYCINE MAX; LACTOBACILLUS HELVETICUS; STREPTOCOCCUS THERMOPHILUS;

EID: 80051571602     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2011.02.004     Document Type: Article

References (43)

1. Bolling B.W., Parkin K.L. Phenolic derivatives from soy flour ethanol extract are potent in vitro quinone reductase (QR) inducing agents. Journal of Agricultural and Food Chemistry 2008, 56(22):10473-10480.
2. Champagne C.P., Green-Johnson J.M., Raymond Y., Barrette J., Buckley N. Selection of probiotic bacteria for the fermentation of a soy beverage in combination with Streptococcus thermophilus. Food Research International 2009, 42:612-621.
3. Champagne C.P., Roy D., Gardner N. Challenges in the addition of probiotic cultures to foods. Critical Reviews in Food Science and Nutrition 2005, 45(1):61-84.
4. Chantry D., Turner M., Abney E., Feldmann M. Modulation of cytokine production by transforming growth factor-beta. Journal of Immunology 1989, 142(12):4295-4300.
5. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 2010, 16(2):228-231.
6. Collins S.M., Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136(6):2003-2014.
7. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. Journal of Immunology 1990, 145(3):940-944.
8. Easo J, Measham JD, Munroe J, & Green-Johnson JM. (2002). Immunostimulatory actions of lactobacilli: mitogenic induction of antibody production and proliferation by Lactobacillus bulgaricus and Lactobacillus acidophilus. Food and Agricultural Immunology, 14, 73-83.
9. Fiander A., Bradley S., Johnson-Green P.C., Green-Johnson J.M. Effects of lactic acid bacteria and fermented milks on eicosanoid production by intestinal epithelial cells. Journal of Food Science 2005, 70:M81-M86.
10. Gareau M.G., Jury J., MacQueen G., Sherman P.M., Perdue M.H. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56(11):1522-1528.
11. Gredel S., Grad C., Rechkemmer G., Watzl B. Phytoestrogens and phytoestrogen metabolites differentially modulate immune parameters in human leukocytes. Food and Chemical Toxicology 2008, 46(12):3691-3696.
12. Hosoi T., Hirose R., Saegusa S., Ametani A., Kiuchi K., Kaminogawa S. Cytokine responses of human intestinal epithelial-like Caco-2 cells to the non-pathogenic bacterium Bacillus subtilis (natto). International Journal of Food Microbiology 2003, 82:255-264.
13. Ishimi Y. Soybean isoflavones in bone health. Forum of Nutrition 2009, 61:104-116.
14. Johnson-Henry K.C., Mitchell D.J., Avitzur Y., Galindo-Mata E., Jones N.L., Sherman P.M. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Digestive Diseases and Sciences 2004, 49(7-8):1095-1102.
15. Johnson-Henry K.C., Nadjafi M., Avitzur Y., Mitchell D.J., Ngan B.Y., Galindo-Mata E., et al. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. The Journal of Infectious Diseases 2005, 191(12):2106-2117.
16. Kaneko K., Iwasaki M., Yoshikawa M., Ohinata K. Orally administered soymorphins, soy-derived opioid peptides suppress feeding and intestinal transit via gut μ1 receptor coupled to 5-HT1A, D2, and GABAB systems. American Journal of Physiology. Gastrointestinal and Liver Physiology 2010, 10.1152/ajpgi.00081.2010.
17. Langermans J.A., Nibbering P.H., Van Vuren-Van Der Hulst M.E., Van Furth R. Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production. Parasite Immunology 2001, 23(4):169-175.
18. Liu J.R., Wang S.Y., Lin Y.Y., Lin C.W. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutrition and Cancer 2002, 44:183-187.
19. Maio M., Del Vecchio L. Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells. Leukemia & Lymphoma 1992, 8(1-2):22-33.
20. Marazza J.A., Garro M.S., de Giori G.S. Aglycone production by Lactobacillus rhamnosus CRL981 during soymilk fermentation. Food Microbiology 2009, 16(3):333-3339.
21. Méndez-Samperio P., García E., Vázquez A., Palma J. Regulation of interleukin-8 by interleukin-10 and transforming growth factor beta in human monocytes infected with mycobacterium bovis. Clinical and Diagnostic Laboratory Immunology 2002, 9(4):802-807.
22. Nagarajan S., Stewart B.W., Badger T.M. Soy isoflavones attenuate human monocyte adhesion to endothelial cell-specific CD54 by inhibiting monocyte CD11a. The Journal of Nutrition 2006, 136(9):2384-2390.
23. Neish A.S. Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunologic Research 2004, 29(1-3):175-186.
24. Ozpolat B., Akar U., Steiner M., Zorrilla-Calancha I., Tirado-Gomez M., Colburn N., et al. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Molecular Cancer Research 2007, 5(1):95-108.
25. Purup S., Vestergaard M., Pederson L.O., Sejrsen K. Biological activity of bovine milk on proliferation of human intestinal cells. The Journal of Dairy Research 2006, 74:58-65.
26. Reid G.R. Probiotics and prebiotics: progress and challenges. International Dairy Journal 2008, 18:969-975.
27. Rizzi M., Tschan M.P., Britschgi C., Britschgi A., Hügli B., Grob T.J., et al. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. Journal of Leukocyte Biology 2007, 81(6):1599-1608.
28. Sakai T., Kogiso M. Soy isoflavones and immunity. The Journal of Medical Investigation 2008, 55(3-4):167-173.
29. Shida K., Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends in Immunology 2008, 29:565-573.
30. Slavik J.M., Hutchcroft J.E., Bierer B.E. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunologic Research 1999, 19(1):1-24.
31. Tsangalis D., Wilcox G., Shah N.P., Stojanovska L. Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. The British Journal of Nutrition 2005, 93(6):867-877.
32. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988, 334(6179):260-262.
33. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457(7228):480-484.
34. Uzzan M., Labuza T.P. Critical issues in R&D of soy isoflavone-enriched foods and dietary supplements. Concise Reviews in Food Science. 2004, 69(3):77-86.
35. Vanden Berghe W., Dijsselbloem N., Vermeulen L., Ndlovu N., Boone E., Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity. Cancer Research 2006, 66(9):4852-4862.
36. Wagar L.E., Champagne C.P., Buckley N.D., Raymond Y., Green-Johnson J.M. Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria. Journal of Food Science 2009, 74(8):M423-M430.
37. Wallace T., Bradley A., Buckley N., Green-Johnson J. Interactions of lactic acid bacteria with human intestinal epithelial cells: Effects on cytokine production. Journal of Food Protection 2003, 66:466-472.
38. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(10):3698-3703.
39. Wood C., Keeling S., Bradley S., Johnson-Green P., Green-Johnson J.M. Vasoactive intestinal peptide modulates the down-regulatory action of Lactobacillus rhamnosus on LPS-induced interleukin-8 production by intestinal epithelial cells. Microbial Ecology in Health and Disease 2007, 19:191-200.
40. Xu B., Chang S.K. Isoflavones, flavan-3-ols, phenolic acids, total phenolic profiles, and antioxidant capacities of soy milk as affected by ultrahigh-temperature and traditional processing methods. Journal of Agricultural and Food Chemistry 2009, 57(11):4706-4717.
41. Yeo S.K., Liong M.T. Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics. International Journal of Food Science and Nutrition 2010, 61(2):161-181.
42. Zareie M., Johnson-Henry K., Jury J., Yang P.C., Ngan B.Y., McKay D.M., et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006, 55(11):1553-1560.
43. Zhang T., Pan W., Takebe M., Schofield B., Sampson H., Li X.-M. Therapeutic effects of a fermented soy product on peanut hypersensitivity is associated with modulation of T-helper type 1 and T-helper type 2 responses. Clinical and Experimental Allergy 2008, 38:1808-1818.